RT Journal Article
SR Electronic
A1 Helwick, Caroline
T1 Final Results of the EORTC Intergroup Randomized Phase 3 Study 40983 Evaluating the Benefit of Perioperative FOLFOX4 Chemotherapy for Patients with Potentially Resectable Colorectal Cancer Liver Metastases
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 3
SP 14
OP 15
DO 10.1177/155989770700700307
UL http://mdc.sagepub.com/content/7/3/14.abstract
AB Perioperative chemotherapy provided benefit for patients with colorectal cancer who were treated with surgery for potentially resectable liver metastases. This article discusses the final Results of the EORTC Intergroup Randomized Phase 3 Study 40983 evaluating the benefit of perioperative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases.